Hot topics in and new strategies for surfactant research

Biology of the Neonate

Volumn 74, Issue SUPPL. 1, 1998, Pages 3-8

  Jobe, Alan H ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Bronchopulmonary dysplasia; Preterm infant; Pulmonary surfactants; Respiratory distress syndrome; Surfactant proteins

Indexed keywords

LUNG SURFACTANT;

ANIMAL TISSUE; CONFERENCE PAPER; HUMAN; HUMAN TISSUE; LUNG DYSPLASIA; LUNG INJURY; LUNG VOLUME; NEWBORN; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

ANIMALS; BIRTH WEIGHT; BRONCHOPULMONARY DYSPLASIA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PULMONARY SURFACTANTS; RESEARCH; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

ANIMALIA;

EID: 0031694721     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047028     Document Type: Conference Paper

References (36)

1. Nogee LM, DeMello DE, Dehner LP, Colten HR: Deficiency of pulmonary surfactant protein B in congenital alveolar proteiosis. N Engl J Med 1993;328:406-410.
2. Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE, Whitsett JA: Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 1995;92:7794-7798.
3. Rider ED, Ikegami M, Whitsett JA, Hull W, Absolom D, Jobe AH: Treatment responses to surfactants containing natural surfactant proteins in preterm rabbits. Am Rev Respir Dis 1993;147:669-676.
4. Suzuki Y, Fujita Y, Kogishi K: Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant. Am Rev Respir Dis 1989;140:75-81.
5. Suzuki Y, Robertson B, Fujita Y, Grossmann G: Respiratory failure in mice caused by a hybridoma making antibodies to the 15 kDa surfactant apoprotein. Acta Anaesthesiol Scand 1988;32:283-289.
6. Vorbroker DK, Profitt SA, Nogee LM, Whitsett JA: Aberrant processing of surfactant protein C (SP-C) in hereditary SP-B deficiency. Am J Physiol 1995;268:L647-L656.
7. Hafner D, Beume R, Kilian U, Krasznai G, Lachmann B: Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS). Br J Pharmacol 1995;115:451-458.
8. Davis AJ, Jobe AH, Häfner D, Ikegami M: Lung function in premature lambs and rabbits treated with a recombinant SP-C surfactant. Am J Respir Crit Care Med 1998;157: 553-559.
9. Wert SE, Profitt S, Whitsett JA, Nogee LM: Reduced SP-C expression in full term infants with RDS (abstract). Pediatr Res 1998;43:303.
10. Beck DC, Na C-L, Weaver TE: Surfactant Protein-B dimerization knockout in transgenic mice (abstract). Am J Respir Crit Care Med 1998;157:557.
11. Hawgood S, Ogawa A, Yukitake K, Schluetter M, Brown C, White T, Buckley D, Lesikar D, Benson B: Lung function in premature rabbits treated with recombinant human surfactant protein-C. Am J Respir Crit Care Med 1996;154:484-490.
12. Korfhagen TR, Bruno MD, Ross GF, Huelsman KM, Ikegami M, Jobe AH, Wert SE, Stripp BR, Morris RE, Glasser SW, Bachurski CJ, Iwamoto HS, Whitsett JA: Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 1996;93:9594-9599.
13. Ikegami M, Korfhagen TR, Whitsett JA, Bruno MD, Wert SE, Wada K, Jobe AH: Characteristics of surfactant from SP-A deficient mice. Am J Physiol 1998, in press.
14. Jobe AH: Pulmonary surfactant therapy. N Engl J Med 1993;328: 861-868.
15. Elkady T, Jobe AH: Corticosteroids and surfactant increase lung volumes and decrease rupture pressures of preterm rabbit lungs. J Appl Physiol 1987;63:1616-1621.
16. Bancalari E: Neonatal chronic lung disease: in Fanaroff AA, Martin RJ (eds): Neonatal-Perinatal Medicine. St. Louis, Mosby, 1997, pp 1074-1089.
17. Soll RF, Merritt TA, Hallman M: Surfactant in the prevention and treatment of respiratory distress syndrome; in Boynton BR, Carlo WA, Jobe AH (eds): New Therapies for Neonatal Respiratory Failure. Cambridge, Cambridge University Press, 1994, pp 49-80.
18. Bjorklund LJ, Vilstrup CT, Larsson A, Svenningsen NW, Werner O: Changes in lung volume and static expiratory pressure-volume diagram after surfactant rescue treatment of neonates with established respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:918-923.
19. Bjorklund LL, Ingimarsson J, Curstedt T, John J, Robertson B, Werner O, Vilstrup CT: Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res 1997;42:348-355.
20. Wada K, Jobe AH, Ikegami M: Tidal volume effects on surfactant treatment responses with the initiation of ventilation in preterm lambs. J Appl Physiol 1997;83:1054-1061.
21. Dreyfuss D, Saumon G: Ventilator-induced lung injury. Am J Respir Crit Care Med 1998;157:294-323.
22. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G: Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995; 126:605-610.
23. Erickson AM, de la Monte SM, Moore GW, Hutchins GM: The progression of morphologic changes in bronchopulmonary dysplasia. Am J Pathol 1987;127:474-487.
24. Watterberg KL, Demers LM, Scott SM, Murphy S: Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97:210-215.
25. Fujimura M, Kitajima H, Nakayama M: Increased leukocyte elastase of the tracheal aspirate at birth and neonatal pulmonary emphysema. Pediatrics 1993;92:564-569.
26. Yoon BH, Romero R, Kim CJ, Koo JN, Choe G, Syn HC, Chi JG: High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol 1997;177:406-411.
27. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI: Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1β, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177:825-830.
28. Hislop AA, Wigglesworth JS, Desai R, Aber V: The effects of preterm delivery and mechanical ventilation on human lung growth. Early Hum Dev 1987;15:147-164.
29. Bry K, Lappalainen U, Hallman M: Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J Clin Invest 1997;99:2992-2999.
30. Emerson GA, Bry K, Hallman M, Jobe AH, Wada N, Ervin MG, Ikegami M: Intra-amniotic interleukin1a treatment alters postnatal adaptation in premature lambs. Biol Neonate 1997;72:370-379.
31. Ikegami M, Jobe AH, Huffman-Reed JA, Whitsett JA: Surfactant metabolic consequences of overexpression of GM-CSF in the epithelium of GM-CSF-defictent mice. Am J Physiol 1997;273:L709-L714.
32. Jain-Vora S, Wert SE, Temann U, Rankin JA, Whitsett JA: Interleukin-4 alters epithelial cell differentiation and surfactant homeostasis in the postnatal mouse lung. Am J Respir Cell Mol Biol 1997;17:541-551.
33. Wispe JR, Clark JC, Warner BB, Fajardo D, Hull WE, Holtzman RB, Whitsett JA: Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein. J Clin Invest 1990;86:1954-1960.
34. Hallman M, Merritt TA, Akino T, Bry K: Surfactant protein-A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid-correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants. Am Rev Respir Dis 1991;144: 1376-1384.
35. Wright JR: Immunomodulatory functions of surfactant. Physiol Rev 1997;77:931-962.
36. Seidner SR, Jobe AH, Ikegami M: Surfactant metabolism during BPD development in preterm baboons (abstract). Am J Respir Crit Care Med 1997;155:236.